Clinical Trial Update: A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

An update on a Phase 2 short-contact plaque test evaluating Daivobet Gel for psoriasis vulgaris, with trial results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Daivobet Gel (calcipotriene and betamethasone dipropionate)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2013-12-24